By Michael Bloom
Publication Date: 2026-01-16 13:42:00
Here are the biggest calls on Wall Street on Friday: Deutsche Bank upgrades Coupang to buy from hold Deutsche says the South Korea online tech company is well positioned to withstand regulatory scrutiny. “Coupang has been receiving unusually large doses of negative regulatory attention, starting with its record breaking antitrust fine from the Korea Fair Trade Commission (KFTC) in June 2024, and pressure has been piling up since the November announcement of a substantial personal data breach.” Read more. Goldman Sachs upgrades BioNTech to buy from neutral Goldman says the biotech company is a share gainer in the oncology space. “We view BNTX as being at the nexus of significant developments occurring in the oncology field, with a broad, strategic suite of programs targeting a potential ~$100bn+ TAM, which will start to see data unlocks in 2026 that could position the company with a leading foothold in an emerging wave of new product cycles.” Barclays downgrades HP to underweight from equal weight Barclays says it sees too many “secular challenges.” “While we see the stock as inexpensive, we believe secular challenges across both PCs and Printing, combined with a lack of catalyst, will cause the stock to remain pressured in 2026. Additionally, we expect the current memory cycle to pressure HPQ’s PC business ( ~30% of Personal Systems is Consumer) with further downside potential in the year.” Macquarie upgrades Nio to outperform from market perform Macquarie says the…
